From Johns Hopkins University School of Medicine, Charlotte J. Sumner, M.D., presents an editorial on a study by Richard S.

The non-coding genome, once dismissed as "junk DNA", is now recognized as a fundamental regulator of gene expression and a ...

Dawnzera is the first and only RNA-targeted prophylactic therapy to be approved for hereditary angioedema in adults and ...

Charlie the Beagle and baby share the most heart-melting high-five ever caught on camera.

A new study suggests an enzyme unique to Homo sapiens may have made us more competitive water seekers than our closest ...

A study of over 10,000 nasal swabs finds that recent rhinovirus infections, the main cause of the common cold, reduce the ...

LYNN — Lynn English High School Senior Antonio Martinez has completed his summer internship with the Broad Institute of MIT ...

Why withdrawal headaches are so painful remains somewhat unclear. Because caffeine affects many parts of the body, experts ...

The New York-bred daughter of Authentic won the restricted stakes by 6 ¾ lengths after posting a 75 Beyer on debut ...

The non-coding genome, once dismissed as "junk DNA", is now recognized as a fundamental regulator of gene expression and a key player in understanding ...

Despite advancements in diagnostic and therapeutic strategies, hepatocellular carcinoma (HCC) remains a leading cause of ...

Developed by Ionis Pharmaceuticals, Dawnzera is the first RNA-targeted medicine approved for HAE, designed to target plasma ...